Highlights and Quick Summary
- Gross Profit for the quarter ending June 30, 2022 was $7.14 Million (a 16.6% increase compared to previous quarter)
- Year-over-year quarterly Gross Profit increased by 29.33%
- Annual Gross Profit for 2021 was $29.4 Million (a 9.76% increase from previous year)
- Annual Gross Profit for 2021 was $26.8 Million (a -12.45% decrease from previous year)
- Annual Gross Profit for 2020 was $30.6 Million (a 26.37% increase from previous year)
- Twelve month Gross Profit ending June 30, 2022 was $29.1 Million (a -2.04% decrease compared to previous quarter)
- Twelve month trailing Gross Profit decreased by -0.68% year-over-year
Trailing Gross Profit for the last four month:
| 30 Jun '22 | 31 Mar '22 | 31 Dec '21 | 30 Sep '21 |
|---|---|---|---|
| $29.1 Million | $29.7 Million | $29.1 Million | $29.3 Million |
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Gross Profit of Biofrontera AG Sponsored ADR
Most recent Gross Profitof BFAGY including historical data for past 10 years.Interactive Chart of Gross Profit of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Gross Profit for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | $7.14 | $6.12 | – |
| 2021 | $10.36 | $5.52 | $7.74 | $5.52 | $29.43 |
| 2020 | $10.55 | $4.25 | $10.06 | $6.26 | $30.63 |
| 2019 | – | $12.95 | $3.83 | $6.64 | $29.56 |
| 2018 | – | – | – | $5.18 | $19.67 |
| 2017 | – | – | $2.42 | $2.4 | $11.65 |
| 2016 | $3.51 | – | – | – | $4.96 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic